Header cover image

Utilities Healthcare Sector

Results

2301

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2301 companies

Astria Therapeutics

Market Cap: US$230.8m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

ATXS

US$4.37

7D

11.5%

1Y

-51.3%

MediWound

Market Cap: US$230.4m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

MDWD

US$21.08

7D

6.0%

1Y

31.7%

Optima Health

Market Cap: UK£170.5m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

OPT

UK£1.92

7D

0.3%

1Y

n/a

Nuvectis Pharma

Market Cap: US$228.3m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

NVCT

US$9.66

7D

-3.9%

1Y

50.5%

Cartesian Therapeutics

Market Cap: US$227.6m

A clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases.

RNAC

US$9.09

7D

-2.0%

1Y

-68.7%

Tactile Systems Technology

Market Cap: US$227.1m

A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

TCMD

US$9.84

7D

-0.1%

1Y

-23.3%

Foghorn Therapeutics

Market Cap: US$225.8m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.

FHTX

US$4.30

7D

5.9%

1Y

-23.6%

Fennec Pharmaceuticals

Market Cap: US$224.5m

Operates as a commercial stage biopharmaceutical company in the United States.

FENC

US$8.12

7D

-2.1%

1Y

13.6%

Tango Therapeutics

Market Cap: US$222.2m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

TNGX

US$1.94

7D

2.6%

1Y

-71.3%

Design Therapeutics

Market Cap: US$220.3m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

DSGN

US$4.00

7D

11.1%

1Y

3.9%

Performant Healthcare

Market Cap: US$220.0m

Provides audit, recovery, and analytics services in the United States.

PHLT

US$2.81

7D

7.7%

1Y

-8.2%

Dimerix

Market Cap: AU$340.6m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

DXB

AU$0.57

7D

-2.6%

1Y

25.3%

Medical Facilities

Market Cap: CA$302.1m

Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.

DR

CA$15.88

7D

3.1%

1Y

34.6%

Annexon

Market Cap: US$216.1m

A clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases.

ANNX

US$2.03

7D

3.0%

1Y

-56.8%

Monopar Therapeutics

Market Cap: US$215.5m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

MNPR

US$32.46

7D

-8.7%

1Y

947.1%

ProKidney

Market Cap: US$213.7m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

PROK

US$0.71

7D

-8.5%

1Y

-82.2%

Aardvark Therapeutics

Market Cap: US$213.1m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

AARD

US$10.21

7D

-8.2%

1Y

n/a

Codexis

Market Cap: US$211.3m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

CDXS

US$2.33

7D

-0.4%

1Y

-27.0%

Integrated Diagnostics Holdings

Market Cap: US$209.3m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

IDHC

US$0.36

7D

0%

1Y

14.3%

Bioventix

Market Cap: UK£154.1m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

BVXP

UK£29.50

7D

3.5%

1Y

-31.4%

OraSure Technologies

Market Cap: US$207.2m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

OSUR

US$2.77

7D

8.8%

1Y

-40.8%

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

VSBC

US$1.00

7D

0%

1Y

n/a

Cardiff Oncology

Market Cap: US$206.2m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

CRDF

US$3.19

7D

10.0%

1Y

-0.3%

enGene Holdings

Market Cap: US$203.9m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

ENGN

US$3.99

7D

-1.2%

1Y

-68.7%

Actuate Therapeutics

Market Cap: US$202.3m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

ACTU

US$10.79

7D

-1.7%

1Y

n/a

Bright Minds Biosciences

Market Cap: CA$278.1m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

DRUG

CA$38.04

7D

-14.5%

1Y

2,037.1%

biote

Market Cap: US$200.0m

Operates in practice-building business within the hormone optimization space.

BTMD

US$3.53

7D

-8.8%

1Y

-47.5%

Y-mAbs Therapeutics

Market Cap: US$199.7m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

YMAB

US$4.62

7D

12.7%

1Y

-62.3%

Quanterix

Market Cap: US$197.4m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

QTRX

US$5.28

7D

9.8%

1Y

-67.4%

SOPHiA GENETICS

Market Cap: US$193.8m

Operates as a cloud-native software technology company in the healthcare space.

SOPH

US$2.87

7D

-2.0%

1Y

-44.2%

ME Therapeutics Holdings

Market Cap: CA$267.1m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

METX

CA$10.26

7D

0%

1Y

157.1%

BioStem Technologies

Market Cap: US$191.4m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

BSEM

US$11.65

7D

-0.9%

1Y

38.5%

4basebio

Market Cap: UK£142.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

4BB

UK£11.10

7D

-1.3%

1Y

-21.0%

CARGO Therapeutics

Market Cap: US$191.4m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

CRGX

US$4.13

7D

1.7%

1Y

-77.1%

Monash IVF Group

Market Cap: AU$296.1m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

MVF

AU$0.77

7D

-1.9%

1Y

-45.8%

Inhibrx Biosciences

Market Cap: US$190.1m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

INBX

US$12.91

7D

-1.9%

1Y

-7.3%

Page 17 of 64